Effectiveness of carbetocin versus oxytocin in the treatment of postpartum hemorrhage: a systematic review
Authors:
- Valeria Stefany Ulloa CazarVCValeria Stefany Ulloa Cazar
- Paola Estefanía Vizñay RamónPRPaola Estefanía Vizñay Ramón
- Antonio Adolfo Paguay SanangoASAntonio Adolfo Paguay Sanango
- Pablo Geovanny Alvarado ZambranoPZPablo Geovanny Alvarado Zambrano
- Katherine Gabriela Borja GonzálesKGKatherine Gabriela Borja Gonzáles
- Dennise Anabella Terreros VintimillaDVDennise Anabella Terreros Vintimilla
Open Access
- 6 July 2026
- journal article
- review article
- Published by Revista Científica Multidisciplinar G-ner@ndo in Revista Científica Multidisciplinar G-NER@NDO
- Vol. 7 (2)
Abstract
Background: Postpartum hemorrhage (PPH) is one of the leading causes of maternal mortality, especially in low- and middle-income countries. Oxytocin and carbetocin are the main recommended treatments, but uncertainty remains about which is more effective in reducing maternal mortality and blood loss. Objective: To compare the effectiveness of carbetocin versus oxytocin in the treatment of PPH through a systematic review of observational studies examining the various risk factors and reductions in blood loss. Methods: A systematic review will be conducted following the PRISMA guidelines. Databases such as PubMed, SciELO, ScienceDirect, and Cochrane will be searched for studies directly comparing the administration of carbetocin and oxytocin in women with PPH. Studies will be selected using the Rayyan platform, and their quality will be assessed using the RoB 1 and RoB 2 tools. Expected results: The review is expected to determine whether carbetocin is more effective than oxytocin in reducing maternal mortality and blood loss. Conclusion: This systematic review will provide an evidence-based overview of the comparative efficacy of these treatments, informing clinical practice in the management of PPH, especially in resource-limited settingsKeywords
This publication has 28 references indexed in Scilit:
- Preventing postpartum hemorrhage with combined therapy rather than oxytocin aloneAmerican Journal of Obstetrics & Gynecology MFM, 2022
- Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and TanzaniaInternational Journal of Gynecology & Obstetrics, 2022
- Scoping Review of Postpartum Discharge Education Provided by NursesJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2022
- Outcomes and complications of severe acute postpartum hemorrhage treated with or without transarterial embolization in a single tertiary referral center: A 20-year experienceTaiwanese Journal of Obstetrics and Gynecology, 2021
- Transvaginal perpendicular cervical wafeform sutures in the treatment of early postpartum hemorrhage caused by lower uterine segment atonyTaiwanese Journal of Obstetrics and Gynecology, 2021
- Postpartum HemorrhageNew England Journal of Medicine, 2021
- Intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labourCochrane Database of Systematic Reviews, 2020
- Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveriesTaiwanese Journal of Obstetrics and Gynecology, 2018
- Global causes of maternal death: a WHO systematic analysisThe Lancet Global Health, 2014
- Carbetocin for preventing postpartum haemorrhage2012